CARRIE MOSLEY: Open Payments
NPI 1336190933 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,322 in 99 payments from 19 companies in 2025. Trend: 2023 $2,461 · 2024 $2,255 · 2025 $2,322
Food & beverage: $2,322
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 27 | $443 |
| Verona Pharma, Inc. | 12 | $342 |
| Merck Sharp & Dohme LLC | 4 | $222 |
| AstraZeneca Pharmaceuticals LP | 11 | $215 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $183 |
| GENZYME CORPORATION | 6 | $179 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $139 |
| Regeneron Healthcare Solutions, Inc. | 4 | $108 |
| Electromed, Inc. | 5 | $93 |
| Insmed, Inc. | 3 | $92 |
Products named: Ohtuvayre, NUCALA, DUPIXENT, WINREVAIR, GLASSIA, AIRSUPRA, TRELEGY ELLIPTA, SMARTVEST.
Industry payments across CA — which companies pay providers there.
